These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9687399)

  • 1. Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.
    Nau R; Lassek C; Kinzig-Schippers M; Thiel A; Prange HW; Sörgel F
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2012-6. PubMed ID: 9687399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.
    Nau R; Kinzig-Schippers M; Sörgel F; Schinschke S; Rössing R; Müller C; Kolenda H; Prange HW
    Antimicrob Agents Chemother; 1997 May; 41(5):987-91. PubMed ID: 9145857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.
    Nau R; Prange HW; Kinzig M; Frank A; Dressel A; Scholz P; Kolenda H; Sörgel F
    Antimicrob Agents Chemother; 1996 Mar; 40(3):763-6. PubMed ID: 8851607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy.
    Pea F; Pavan F; Nascimben E; Benetton C; Scotton PG; Vaglia A; Furlanut M
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3104-8. PubMed ID: 14506016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
    Lodise TP; Nau R; Kinzig M; Drusano GL; Jones RN; Sörgel F
    J Antimicrob Chemother; 2007 Nov; 60(5):1038-44. PubMed ID: 17785282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery.
    Zhang Y; Zhang J; Chen Y; Yu J; Cao G; Wu X; Chen M; Wu J; Zhao X
    World Neurosurg; 2017 Feb; 98():525-531. PubMed ID: 27867128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.
    Nau R; Kinzig M; Dreyhaupt T; Kolenda H; Sörgel F; Prange HW
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1849-53. PubMed ID: 7986019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.
    Nau R; Prange HW; Menck S; Kolenda H; Visser K; Seydel JK
    J Antimicrob Chemother; 1992 Jun; 29(6):719-24. PubMed ID: 1506352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients.
    Tsumura R; Ikawa K; Morikawa N; Ikeda K; Shibukawa M; Iida K; Kurisu K
    J Chemother; 2008 Oct; 20(5):615-21. PubMed ID: 19028626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study.
    Blassmann U; Roehr AC; Frey OR; Vetter-Kerkhoff C; Thon N; Hope W; Briegel J; Huge V
    Crit Care; 2016 Oct; 20(1):343. PubMed ID: 27776537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cerebrospinal fluid diffusion of imipenem and meropenem in rats.
    Dupuis A; Caillaud A; Pariat C; Courtois P; Couet W; Bouquet S
    J Pharm Pharmacol; 2000 Sep; 52(9):1143-9. PubMed ID: 11045896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of continuous-infusion meropenem for the treatment of Serratia marcescens ventriculitis in a pediatric patient.
    Cies JJ; Moore WS; Calaman S; Brown M; Narayan P; Parker J; Chopra A
    Pharmacotherapy; 2015 Apr; 35(4):e32-6. PubMed ID: 25884534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.
    Myrianthefs P; Markantonis SL; Vlachos K; Anagnostaki M; Boutzouka E; Panidis D; Baltopoulos G
    Antimicrob Agents Chemother; 2006 Dec; 50(12):3971-6. PubMed ID: 16982782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations.
    Lonsdale DO; Udy AA; Roberts JA; Lipman J
    J Neurosurg; 2013 Feb; 118(2):297-301. PubMed ID: 23121433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transferability of meropenem to cerebrospinal fluid in rabbits with meningitis caused by Staphylococcus aureus].
    Haruta T; Okura K; Kuroki S; Nikami H; Kobayashi Y
    Jpn J Antibiot; 1992 Jul; 45(7):809-13. PubMed ID: 1522671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.
    Nau R; Zysk G; Thiel A; Prange HW
    Eur J Clin Pharmacol; 1993; 45(5):469-75. PubMed ID: 8112378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery.
    Lu C; Zhang Y; Chen M; Zhong P; Chen Y; Yu J; Wu X; Wu J; Zhang J
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6619-6625. PubMed ID: 27572392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis.
    Ohata Y; Tomita Y; Sunakawa K; Drusano GL; Tanigawara Y
    Int J Antimicrob Agents; 2019 Sep; 54(3):292-300. PubMed ID: 31279154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.
    Nau R; Prange HW; Muth P; Mahr G; Menck S; Kolenda H; Sörgel F
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1518-24. PubMed ID: 8363385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol.
    Nau R; Prins FJ; Kolenda H; Prange HW
    Eur J Clin Pharmacol; 1992; 42(2):181-5. PubMed ID: 1618250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.